HPV legislation in South Carolina

From SourceWatch
Jump to: navigation, search

Women in Government Ratings

Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" [1]:


POPULATION: 4,321, 249


Incidence & Mortality (2008 Score / 2007 Score)

  • Cervical Cancer Incidence Rate: 8.2/100,000 (1/ 1)
  • Cervical Cancer Incidence Rate/Race: White: 7.0, Black: 11.1
  • Cervical Cancer Mortality Rate: 2.3/100,000 (1 / 1)
  • Cervical Cancer Mortality Rate/Race: White: 1.4, Black: 4.6


Screening (2008 Score / 2007 Score)

  • Cervical Cancer Screening Rate: 86.8% (2 / 2)
  • Cervical Cancer Screening Rate/Race: White: 90%, Black: 90.6%, Hispanic: 87.6%
  • % Uninsured/Unscreened: 20.3% (2 / 2)
  • Medicaid Coverage HPV Testing: Unrestricted (2 / 2)


Healthcare Access (2008 Score / 2007 Score)

  • Rate Uninsured Women: 20% (1 / 1)
  • % Low Income/Uninsured Women: 36%


Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)

Screening Requirements (0 / 1)

  • There are no new screening requirements.

Task Forces (0 / 1)

  • There is no new cervical cancer prevention task force legislation.

Access to HPV Vaccines (1 / 1)

  • HB 3136 would require female students enrolling in the 7th grade to have received the HPV vaccine consistent with existing immunization exemptions; died in House.

HPV Vaccine Information Programs (0 / 0)

  • There is no HPV vaccine information activity.

Miscellaneous (0 / 0)

  • There is no new miscellaneous cervical cancer prevention activity.


Annual Ratings

  • 2008: Good (12 out of 22 points)
  • 2007: Good (11 out of 18 points)


Articles and resources

SourceWatch Resources

External links

References